METOCLOPRAMIDE INDUCED GROWTH HORMONE RELEASE IN HYPOGONADAL MALES

H. N. COHEN, I. D. HAY, G. H. BEASTALL, J. A. THOMSON

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

The growth hormone (GH) response to 10 mg intravenous metoclopramide (MCP) (‘Maxo1on’‐Beecham Laboratories) was determined in ten hypogonadal adult males. All the subjects responded with a peak growth hormone level > 14 mU/1 within 1 hour of administration of MCP. Seven normal adult males did not respond to MCP administration. It is concluded that MCP stimulation may be a useful test for both prolactin and growth hormone reserve in hypogonadal males.

Original languageEnglish (US)
Pages (from-to)95-97
Number of pages3
JournalClinical Endocrinology
Volume11
Issue number1
DOIs
StatePublished - Jul 1979

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'METOCLOPRAMIDE INDUCED GROWTH HORMONE RELEASE IN HYPOGONADAL MALES'. Together they form a unique fingerprint.

  • Cite this